share_log

中國生物製藥：股東週年大會通告

SINO BIOPHARM: NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 29 04:45
Summary by Moomoo AI
中國生物製藥有限公司將於2024年6月5日舉行股東週年大會，會議將以實體會議結合線上虛擬會議的混合模式進行。會議的主要議程包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表、董事會報告及獨立核數師報告，批准派發末期股息，以及重選謝炳先生、陸正飛先生和李大魁先生為董事。此外，會議還將授權董事會釐定董事酬金，續聘安永會計師事務所為下一財年的核數師並釐定其酬金。股東大會還將考慮通過特別決議案，包括授權董事在特定期間內配發新股份、回購公司股份，以及擴大處理額外股份的一般授權。股份過戶登記將於2024年5月31日至6月5日暫停，以釐定有權出席大會及投票的股東，並於6月13日至18日暫停，以釐定有權收取末期股息的股東。
中國生物製藥有限公司將於2024年6月5日舉行股東週年大會，會議將以實體會議結合線上虛擬會議的混合模式進行。會議的主要議程包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表、董事會報告及獨立核數師報告，批准派發末期股息，以及重選謝炳先生、陸正飛先生和李大魁先生為董事。此外，會議還將授權董事會釐定董事酬金，續聘安永會計師事務所為下一財年的核數師並釐定其酬金。股東大會還將考慮通過特別決議案，包括授權董事在特定期間內配發新股份、回購公司股份，以及擴大處理額外股份的一般授權。股份過戶登記將於2024年5月31日至6月5日暫停，以釐定有權出席大會及投票的股東，並於6月13日至18日暫停，以釐定有權收取末期股息的股東。
CHINA BIOPHARMACEUTICAL CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 5, 2024. THE MEETING WILL BE HELD IN A HYBRID MODE OF PHYSICAL MEETINGS COMBINED WITH ONLINE VIRTUAL MEETINGS. THE MAIN AGENDA OF THE MEETING INCLUDES THE REVIEW AND ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023, THE BOARD'S REPORT AND THE INDEPENDENT AUDITOR'S REPORT, THE APPROVAL OF THE DISTRIBUTION OF THE FINAL DIVIDEND, AND THE RE-ELECTION OF MR. XIE PING, MR. LU ZHENFEI AND MR. LI TAI QUAI AS DIRECTORS. In addition, the meeting will authorize the Board of Directors to determine the remuneration of directors, to renew and determine the remuneration of EY Accountants as auditor for the next financial year...Show More
CHINA BIOPHARMACEUTICAL CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 5, 2024. THE MEETING WILL BE HELD IN A HYBRID MODE OF PHYSICAL MEETINGS COMBINED WITH ONLINE VIRTUAL MEETINGS. THE MAIN AGENDA OF THE MEETING INCLUDES THE REVIEW AND ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023, THE BOARD'S REPORT AND THE INDEPENDENT AUDITOR'S REPORT, THE APPROVAL OF THE DISTRIBUTION OF THE FINAL DIVIDEND, AND THE RE-ELECTION OF MR. XIE PING, MR. LU ZHENFEI AND MR. LI TAI QUAI AS DIRECTORS. In addition, the meeting will authorize the Board of Directors to determine the remuneration of directors, to renew and determine the remuneration of EY Accountants as auditor for the next financial year. The General Meeting will also consider the adoption of a special resolution, including authorizing directors to issue new shares within a specified period, repurchase company shares, and expand general mandates to process additional shares. The registration of shares will be suspended from 31 May to 5 June 2024 to determine the shareholders entitled to attend the general meeting and vote, and will be suspended from 13 to 18 June to determine the shareholders entitled to receive the final dividend.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more